Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


20.11.2017

1 Am Heart J
1 Am J Cardiol
1 BMJ
1 Circ Cardiovasc Qual Outcomes
5 Circ Heart Fail
1 Circulation
10 Eur J Heart Fail
3 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. SHADDY R, Canter C, Halnon N, Kochilas L, et al
    Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).
    Am Heart J. 2017;193:23-34.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. KOK W, Salah K, Stienen S
    Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure: Identifying Possible Threats to Outcome.
    Am J Cardiol. 2017 Oct 13. pii: S0002-9149(17)31604.
    PubMed     Text format    


    BMJ

  3. HAWKES N
    The BMJ Awards 2017: Cardiology.
    BMJ. 2017;357:j1912.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  4. CHIA YMF, Teng TK, Tan ESJ, Tay WT, et al
    Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  5. KHERA R, Pandey A, Ayers CR, Agusala V, et al
    Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available

  6. SAEED O, Rangasamy S, Selevany I, Madan S, et al
    Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available

  7. DEFILIPPIS EM, Butler J, Vaduganathan M
    Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.
    Circ Heart Fail. 2017;10.
    PubMed     Text format    

  8. SHEN L, Ramires F, Martinez F, Bodanese LC, et al
    Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available

  9. VAN TASSELL BW, Canada J, Carbone S, Trankle C, et al
    Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available


    Circulation

  10. FELDMAN T, Mauri L, Kahwash R, Litwin S, et al
    A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.117.032094.
    PubMed     Text format     Abstract available


    Eur J Heart Fail

  11. PALAU P, Dominguez E, Nunez J
    Clinical utility of cardiopulmonary exercise testing in patients with heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1066.
    PubMed     Text format    

  12. LOURENCO AP, Leite-Moreira AF, Balligand JL, Bauersachs J, et al
    An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1059.
    PubMed     Text format     Abstract available

  13. SELVARAJ S, Claggett B, Shah SJ, Anand I, et al
    Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1060.
    PubMed     Text format     Abstract available

  14. GHIO S, Crimi G, Temporelli PL, Traversi E, et al
    Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1067.
    PubMed     Text format     Abstract available

  15. ZENG DX
    Iron deficiency and red cell indices in patients with heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1052.
    PubMed     Text format    

  16. GO YY, Sugimoto T, Bulluck H, Acharyya S, et al
    Age and ejection fraction modify the impact of atrial fibrillation on acute heart failure outcomes.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1075.
    PubMed     Text format    

  17. RORTH R, Fosbol EL, Mogensen UM, Kragholm K, et al
    Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1046.
    PubMed     Text format     Abstract available

  18. VADUGANATHAN M, Cheema B, Cleveland E, Sankar K, et al
    Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002.
    PubMed     Text format     Abstract available

  19. SLIWA K, van Hagen IM, Budts W, Swan L, et al
    Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
    Eur J Heart Fail. 2016 Jul 7. doi: 10.1002.
    PubMed     Text format     Abstract available

  20. SCHNEIDER D, Flores D, Mueller C
    Risk stratification in acute heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1057.
    PubMed     Text format    


    J Am Coll Cardiol

  21. SHAH KS, Xu H, Matsouaka RA, Bhatt DL, et al
    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39761.
    PubMed     Text format     Abstract available

  22. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Text format     Abstract available

  23. STEINBERG BA, Fang JC
    Long-Term Outcomes of Acute Heart Failure: Where Are We Now?
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39762.
    PubMed     Text format    


    J Cardiovasc Pharmacol

  24. COLE-JEFFREY CT, Pepine CJ, Katovich MJ, Grant MB, et al
    Beneficial Effects Of Angiotensin-(1-7) On Cd34 + Cells From Heart Failure Patients.
    J Cardiovasc Pharmacol. 2017 Nov 8. doi: 10.1097/FJC.0000000000000556.
    PubMed     Text format     Abstract available


    N Engl J Med

  25. ELLISON DH, Felker GM
    Diuretic Treatment in Heart Failure.
    N Engl J Med. 2017;377:1964-1975.
    PubMed     Text format    


    PLoS One

  26. GORODESKI EZ, Joyce E, Gandesbery BT, Blackstone EH, et al
    Discordance between 'actual' and 'scheduled' check-in times at a heart failure clinic.
    PLoS One. 2017;12:e0187849.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: